Clinical trial · Interventional
Multilevel Intervention for Precision Oncology
Multilevel Veteran-centric Intervention to Improve Precision Oncology
NCT06825715CI-TRIAL-00117147MIPOrecruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators are rolling out a 3 level intervention designed to improve the use of Precision Oncology at 8 VA medical centers. The 3 components of the intervention are 1: a short educational video for patients, 2: audit and feedback to providers on their Precision Oncology practice patterns, and 3: a change in the electronic medical record to make it easier to order and review results of Precision Oncology tests.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Cancers of the Prostate | — | UNRESOLVED | — |
| Cancers of the Lung | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Multilevel intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- During intervention period
- description
- All sites will receive the 3 level intervention of patient education, provider audit/feedback, and EMR order change.
- interventionNames
- Other: Multilevel intervention
Primary outcomes (1)
- measure
- Use of molecular testing
- timeFrame
- 3 years
- description
- Proportion of eligible patients with lung and prostate cancer who have next generation sequencing molecular testing
Secondary outcomes (1)
- measure
- Use of targeted therapy
- timeFrame
- 3 years
- description
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients in the VA with cancer of the lung or prostate who are seen in the oncology clinic Exclusion Criteria: * Cancer that did not originate in the prostate or the lung
References
Publications (0)
Data not yet available
No reference posted for this study.